NY Times

Baltimore Vaccine Plant’s Troubles Ripple Across 3 Continents

Millions of doses of Johnson & Johnson’s Covid-19 vaccine produced by Emergent BioSolutions have been held back in Europe, South Africa and Canada as a precaution.

Continue

About the author

Darlene

Leave a Comment